Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Allegra

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
The Oncologist|June 8, 2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic AdenocarcinomaThomas J George, Azka Ali, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferonJ L Grem, N McAtee, R F Murphy, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinomaEllie Chan, Lizette Vila Duckworth, Ahmad Alkhasawneh, et al.
NIH Consensus and State-Of-The-Science Statements|September 29, 2009
NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS)Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patientsC H Takimoto, W Dahut, M T Marino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of the National Cancer Institute|January 15, 2010
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancerCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prognostic importance of thymidylate synthase expression in early breast cancerB C Pestalozzi, H F Peterson, R D Gelber, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
The Oncologist|June 8, 2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic AdenocarcinomaThomas J George, Azka Ali, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferonJ L Grem, N McAtee, R F Murphy, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinomaEllie Chan, Lizette Vila Duckworth, Ahmad Alkhasawneh, et al.
NIH Consensus and State-Of-The-Science Statements|September 29, 2009
NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS)Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patientsC H Takimoto, W Dahut, M T Marino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of the National Cancer Institute|January 15, 2010
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancerCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prognostic importance of thymidylate synthase expression in early breast cancerB C Pestalozzi, H F Peterson, R D Gelber, et al.
Pageof 22